Differential expression of the T cell inhibitor TIGIT in Glioblastoma and Multiple Sclerosis
L. E. Lucca, B. A. Lerner, D. DeBartolo, C. Park, G. Ponath, K. Raddassi, D. A. Hafler, D. Pitt
The paper compares TIGIT expression in glioblastoma tumor-infiltrating T cells and multiple sclerosis lesions, finding higher TIGIT expression in GBM and suggesting anti-TIGIT therapy as a potential treatment.
bioRxiv · Mar 27, 2019 · PreprintImmunology